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OBJECTIVE—We investigated the role of cytochrome P450 of
the 4A family (CYP4A), its metabolites, and NADPH oxidases
both in reactive oxygen species (ROS) production and apoptosis
of podocytes exposed to high glucose and in OVE26 mice, a
model of type 1 diabetes.
RESEARCH DESIGN AND METHODS—Apoptosis, albumin-
uria, ROS generation, NADPH superoxide generation, CYP4A and
Nox protein expression, and mRNA levels were measured in
vitro and in vivo.
RESULTS—Exposure of mouse podocytes to high glucose re-
sulted in apoptosis, with approximately one-third of the cells
being apoptotic by 72 h. High-glucose treatment increased ROS
generation and was associated with sequential upregulation of
CYP4A and an increase in 20-hydroxyeicosatetraenoic acid (20-
HETE) and Nox oxidases. This is consistent with the observation
of delayed induction of NADPH oxidase activity by high glucose.
The effects of high glucose on NADPH oxidase activity, Nox
proteins and mRNA expression, and apoptosis were blocked by
N-hydroxy-N-(4-butyl-2-methylphenol) formamidine (HET0016),
an inhibitor of CYP4A, and were mimicked by 20-HETE. CYP4A
and Nox oxidase expression was upregulated in glomeruli of type
1 diabetic OVE26 mice. Treatment of OVE26 mice with HET0016
decreased NADPH oxidase activity and Nox1 and Nox4 protein
expression and ameliorated apoptosis and albuminuria.
CONCLUSIONS—Generation of ROS by CYP4A monooxygen-
ases, 20-HETE, and Nox oxidases is involved in podocyte apo-
ptosis in vitro and in vivo. Inhibition of selected cytochrome P450
isoforms prevented podocyte apoptosis and reduced proteinuria
in diabetes. Diabetes 58:1201–1211, 2009
D
iabetic nephropathy in humans is characterized
by increased urinary albumin excretion (mi-
croalbuminuria), which often progresses to pro-
teinuria, one of the most important prognostic
risk factors for kidney disease progression (1). Glomerular
visceral epithelial cells, or podocytes, play a critical role in
maintaining the structure and function of the glomerular
ﬁltration barrier. Careful morphometric analyses of renal
biopsy in subjects with type 1 and type 2 diabetes (2–4)
demonstrate that the density of podocytes is reduced not
only in individuals with diabetic nephropathy, but also in
patients with short duration of diabetes before the onset of
microalbuminuria (4,5). Studies in experimental models of
type 1 and type 2 diabetes have also documented that
podocyte depletion represents one of the earliest cellular
lesions affecting the diabetic kidney (6,7). Among various
morphologic characteristics, the decreased number of
podocytes in glomeruli is the strongest predictor of pro-
gression of diabetic nephropathy, where fewer cells pre-
dict more rapid progression (3,4). Although these
observations identify podocyte depletion as one of the
earliest cellular features of diabetic kidney disease, the
mechanisms that underlie the loss of podocytes in diabetic
nephropathy remain poorly understood.
High glucose induces apoptosis (8), and there is evi-
dence that podocyte apoptosis contributes to reduced
podocyte number (9). High glucose, transforming growth
factor- (TGF-), and angiotensin II (ANGII) induce apo-
ptosis of cultured podocytes (9–12). ANGII appears to
induce apoptosis in cultured rat glomerular epithelial cells
at least partially via TGF- because its apoptotic effect is
attenuated by an anti–TGF- antibody (12). There is also
evidence that reactive oxygen species (ROS) contribute to
podocyte apoptosis and depletion in cells exposed to high
glucose and in experimental diabetic nephropathy (7).
However, the sources of ROS and the kinetics of their
generation have not been well characterized. We and
others (13–15) have recently identiﬁed NADPH oxidases
as major sources of ROS in kidney cortex and glomeruli of
rats with type 1 diabetes. Six homologs of the cytochrome
subunit of the phagocyte NADPH oxidase (Nox2/gp91
phox)
have been cloned (16). At least three different Nox iso-
forms are expressed in the kidney cortex: Nox1, Nox2, and
Nox4 (16). Cytochromes P450 (CYP450s) are signiﬁcant
sources of ROS in many tissues (17,18). CYP450 metabo-
lizes arachidonic acid into hydroxyeicosatetraenoic acids
(20-HETEs) and EETs (epoxyeicosatrienoic acids). 20-
HETE, the -hydroxylation product of arachidonic acid, is
one of the major CYP eicosanoids produced in the kidney
cortex (19–21). The predominant CYP450 in the kidney
cortex that synthesizes 20-HETE is cytochrome P450 of
the 4A family (CYP4A) (19–21). 20-HETE has multiple and
opposing functions depending on the site of production
and target cells/tissues (19,22–24).
In this study, we demonstrate that high glucose induces
ROS production and apoptosis in cultured mouse podo-
cytes through the upregulation of CYP4A with increased
production of 20-HETE and upregulation of NADPH oxi-
dases. Inhibition of 20-HETE production prevented podo-
cyte apoptosis in vitro and decreased oxidative stress,
podocyte apoptosis, and proteinuria in an in vivo model of
type 1 diabetes.
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Conditionally immortalized mouse podocytes, kindly provided by Dr. Peter
Mundel (University of Florida, Miami, Florida), were cultured as previously
described (20,25). In brief, cells were ﬁrst grown under permissive conditions
at 33°C in RPMI-1640 media containing 10% FCS, 50 units/ml interferon(IFN)-
(IFN), and 100 units/ml of penicillin/streptomycin in collagen-coated ﬂasks.
Concentration of IFN- was then tapered to 10 units/ml, and cells were
subcultivated under nonpermissive conditions (37°C) in serum-containing
medium without IFN-. Near-conﬂuent cells were growth-arrested in RPMI-
1640 containing 0.2% BSA (fatty-acid free) and 5 mmol/l D-glucose for 24 h
before the experiment.
Animal models. We used 7-month-old FVB and OVE26 mice on FVB
background (Jackson Laboratories, Bar Harbor, ME). At 6 months of age,
OVE26 mice were treated with N-hydroxy-N-(4-butyl-2-methylphenol) forma-
midine (HET0016), a speciﬁc inhibitor of CYP4A, for 3 weeks. Mice were
placed in metabolic cages for urine collection, and before the treatment with
HET0016, urine albumin was measured by an Albuwell M test kit (Exocell,
Philadelphia, PA) and expressed as micrograms of albumin per 24 h. Animals
were killed by exsanguination under anesthesia. Both kidneys were removed
and weighed. A slice of kidney cortex at the pole was embedded in parafﬁn or
ﬂash-frozen in liquid nitrogen for microscopy and image analyses. Cortical
tissue was used for isolation of glomeruli by differential sieving with minor
modiﬁcation as previously described (26).
Detection of intracellular ROS. The peroxide-sensitive ﬂuorescent probe
2,7-dichlorodihydroﬂuorescin (DCF) diacetate (Molecular Probes) was used
to measure intracellular ROS as previously described (15). Cells were grown
in 12- or 24-well plates and serum-deprived for 24 h. Immediately before the
experiments, cells were washed with Hank’s buffered salt solution containing
Ca
2 and Mg
2 and then loaded with 50 mol/l DCF diacetate dissolved in
Hank’s buffered salt solution for 30 min at 37°C. Cells were then incubated for
45 min with HET0016 followed by the addition of the agonist or vehicle for
various time periods. DCF ﬂuorescence was detected at excitation and
emission wavelengths of 488 and 520 nm, respectively, and measured in a
multiwell ﬂuorescence plate reader (Wallac 1420 Victor
2; PerkinElmer).
NADPH oxidase activity. NADPH oxidase activity was measured in podo-
cytes grown in serum-free medium or in glomeruli isolated from kidney cortex
as previously described (13). Cultured podocytes were washed ﬁve times in
ice-cold PBS and scraped from the plate in the same solution followed by
centrifugation at 800 rpm, 4°C, for 10 min. The cell pellets were resuspended
in lysis buffer (20 mmol/l KH2PO4, pH 7.0, 1 mmol/l EGTA, 1 mmol/l
phenylmethylsulfonyl ﬂuoride (PMSF), 10 g/ml aprotinin, and 0.5 g/ml
leupeptin). Cell suspensions or washed glomeruli were homogenized with 100
strokes in a Dounce homogenizer on ice. To start the assay, 20 go f
homogenates were added to 50 mmol/l phosphate buffer, pH 7.0, containing 1
mmol/l EGTA, 150 mmol/l sucrose, 5 mol/l lucigenin, and 100 mol/l NADPH.
Photon emission expressed as relative light units was measured every 20 or
30 s for 10 min in a luminometer. A buffer blank (5% of the cell signal) was
subtracted from each reading. Superoxide production was expressed as
relative light units per milligrams of protein. Protein content was measured
using a Bio-Rad protein assay reagent.
Isolation of microsomes. Podocytes in serum-free medium or glomeruli
isolated from kidney cortex were homogenized in a 10 mmol/l potassium
phosphate buffer, pH 7.7, containing 250 mmol/l sucrose, 1 mmol/l EDTA, 10
mmol/l magnesium chloride, 2 mol/l leupeptin, 1 mol/l pepstatin, 2 g/ml
aprotinin, and 0.1 mol/l PMSF. Microsomes were prepared by differential
centrifugation as previously described (27,28) and used for Western blotting
and 20-HETE measurement by high-performance liquid chromatography
(HPLC).
Western blotting analysis. Homogenates from glomeruli isolated from renal
cortex were prepared in 200 l of radioimmune precipitation assay buffer (20
mmol/l TrisHCl, pH 7.5, 150 mmol/l NaCl, 5 mmol/l EDTA, 1 mmol/l Na3VO4,
1 mmol/l PMSF, 20 g/ml aprotinin, 20 g/ml leupeptin, and 1% NP-40) using
a Dounce homogenizer. Homogenates were incubated for1ha t4 ° Ca n d
centrifuged at 10,000 rpm for 30 min at 4°C.
Mice podocytes were grown to near conﬂuency in 60- or 100-mm dishes
and serum deprived for 24 h. All incubations were carried out in serum-free
RPMI containing 0.2% BSA (fatty acid free) at 37°C for a speciﬁed duration.
The cells were lysed in radioimmune precipitation buffer at 4°C for 30 min.
The cell lysates were centrifuged at 10,000 rpm for 30 min at 4°C. Protein in
the supernatants was measured using the Bio-Rad method. For immunoblot-
ting, proteins (40–80 g) were separated on 12.5% SDS-PAGE and transferred
to polyvinylidene diﬂuoride membranes. Blots were incubated with rabbit
polyclonal anti-Nox1 (1:200 H-75; Santa Cruz Biotechnology), rabbit poly-
clonal anti-Nox2 (1:1,000; Upstate), rabbit polyclonal anti-Nox4 (1:1,000;
Novus Biological), and rabbit polyclonal anti-CYP4A (1:500, Abcam). The
primary antibodies were detected using horseradish peroxidase–conjugated
IgG (1:2,500 or 1:5,000). Bands were visualized by enhanced chemilumines-
cence. Densitometric analysis was performed using National Institutes of
Health Image software.
20-HETE production. Levels of 20-HETE were measured in isolated micro-
somes by HPLC. In short, [1-
14C]-labeled arachidonic acid (50–100 mol/l)
was dried down and resuspended in the reaction mix containing 50 g
microsomes, 30 mmol/l isocitrate, and 0.2 unit isocitrate dehydrogenase in
reaction buffer (100 mmol/l potassium phosphate, pH 7.4, 5 mmol/l magnesium
chloride, and 1 mmol/l EDTA). After incubation at 37°C for 5 min, the reaction
was initiated by the addition of NADPH to a ﬁnal concentration of 1 mmol/l.
Aliquots were removed at 30, 60, and 90 min, and the reaction was stopped by
the addition of 100% methanol. The precipitated proteins were then pelleted
by centrifugation (in a microcentrifuge), and the samples were stored at
20°C until analyzed. The metabolites were separated via HPLC on a C-18
column using an acetonitrile/H20 gradient and identiﬁed by coelution with
labeled standards.
mRNA analysis. mRNA was analyzed by real-time RT-PCR using the 		Ct
method. Total RNA was isolated from cultured mouse podocytes using an
RNeasy Mini kit from Qiagen. mRNA expression was quantiﬁed using a
Realplex mastercycler (Eppendorf, Westbury, NY) with SYBR green dye and
mouse RT
2 qPCR Primers (SABiosciences, Frederick, MD) for Nox1 (se-
quence accession no. NM_172203) and Nox4 (sequence accession no.
NM_015760) and normalized to GAPDH.
Hoechst staining. Cells were plated on plastic four-chamber slides. Apopto-
tic nuclei were detected using Hoechst 33258 (Fluka) staining (1 g/ml, 30
min) in cells ﬁxed with 4% paraformaldehyde and analyzed via ﬂuorescence
microscopy at 350-nm excitation and 460-nm emission.
Annexin V and propidium iodide staining. An annexin V–ﬂuorescein
isothiocyanate (FITC) apoptosis detection kit (Calbiochem) was used for
annexin V and propidium iodide staining according to the manufacturer
protocol. Podocytes were cultured in 60 mm dishes to 
 80% conﬂuency and
serum-starved for 24 h. Cells were then preincubated with or without 10
mol/l HET0016 before the addition of glucose (25 mmol/l) or 1 mol/l of
20-HETE. Cells were then incubated for 24, 48, or 72 h at 37°C. The percentage
of apoptotic and necrotic cells was assessed by ﬂuorescence-activated cell
sorting (San Antonio Cancer Institute core facility of the University of Texas
Health Science Center San Antonio).
Electron microscopy. Kidney cortexes isolated from the FVB, OVE 26, and
OVE26 mice treated with HET0016 were cut into 0.5- to 1-mm
3 pieces and
ﬁxed overnight in cold 4% formaldehyde and 1% glutaraldehyde in phosphate
buffer and then embedded in epon 812 resin. Then, 0.5-mm plastic sections
were cut and stained with toluidine blue for identiﬁcation of representative
areas for subsequent sectioning by ultramicrotome. Ultrathin sections were
stained with uranyl acetate and examined and photographed on a JEOL 100CX
electron microscope. All electron microscope (EM) photomicrographs were
examined in a blind fashion. Individual capillary loops were examined and
quantiﬁed in ﬁve glomeruli per group of animals (FVB, OVE26, and OVE 26
mice treated with HET0016) for the degree of foot process effacement as
described by Jo et al. (29).
Podocyte enumeration. Dual-label immunohistochemistry was used to
identify and count glomerular epithelial cells relative to the glomerular
basement membrane (GBM) using a modiﬁcation of methods previously
described (30). To identify podocytes, 3-m frozen sections of kidney cortex
on glass slides were stained with a goat anti-synaptopodin antibody (Santa
Cruz Biotechnology) followed by Cy3-labeled donkey anti-goat IgG (Chemi-
con). After washing, and to identify the GBM, the sections were stained with
a rabbit antibody directed against collagen type IV (Chemicon) followed by
FITC-labeled donkey anti-rabbit IgG (Chemicon). After staining and washing,
the sections were preserved on coverslips in Prolong gold antifade mounting
medium with 4,6-diamidino-2-phenylindole (Invitrogen) for the ﬂuorescence
detection of nuclei. Sections were examined by epiﬂuorescence using excita-
tion and band-pass ﬁlters optimal for FITC, Cy3, and 4,6-diamidino-2-
phenylindole. Digital images representing each ﬂuorochrome were taken of
random glomeruli using an AX70 Research microscope and a DP70 digital
camera (Olympus, Melville, NY). Then, 25–30 glomerular cross-sections per
animal were photographed in each color channel providing a minimum of 100
composite images per experimental group. The images were merged and color
balanced using Image-Pro Plus imaging software (Media Cybernetics, Silver
Spring, MD), and podocytes were counted in projected images in a blind
fashion by two individuals. Synaptopodin-positive cells on the outer aspect of
the GBM were considered glomerular epithelial cells and counted. Synaptopo-
din-negative cells or those in the inner aspect of the GBM were not counted.
The mean area of each glomerular proﬁle was measured manually, tracing the
glomerular outline, encircling the area of interest, and calculating the surface
area by computerized morphometry using MetaMorph 4.69. The results were
expressed as the average number of podocytes per glomerular section as
previously described (31–33).
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High glucose induces oxidative stress in podocytes.
Exposure of podocytes to 25 mmol/l glucose (high glu-
cose) results in a relatively rapid generation of ROS, as
measured by DCF ﬂuorescence, compared with cells incu-
bated in 5 mmol/l glucose (normal glucose) or mannitol
used as an osmotic control. ROS generation was detected
after6ho fexposure to high glucose and was sustained up
to 72 h (Fig. 1A). NADPH oxidases of the Nox family are
major sources of ROS in cells and tissue (13,15,16).
However, there was no increase in NADPH-dependent
superoxide generation 6 h after exposure of the cells to
high glucose (Fig. 1C). The increase in NADPH oxidase
activity was detectable only at 12 h and remained sus-
tained up to 72 h (Fig. 1B), suggesting that other sources of
ROS besides NADPH oxidases were involved in the ROS
generation seen at early time points after treatment with
high glucose. Consistent with these observations, we
found that upregulation of the two major Nox isoforms,
Nox1 and Nox4, was not seen before 12 and 24 h,
respectively. Note that Nox2 isoform expression was not
altered by high-glucose treatment.
High glucose induces CYP4A protein expression and
20-HETE production. We next examined whether
CYP4A contributes to oxidative stress induced by high
glucose in mouse podocytes. Microsomes were isolated
from podocytes incubated in normal or high glucose. Our
data show that CYP4A protein expression was increased in
microsomes isolated from podocytes incubated in the
presence of high glucose compared with podocytes incu-
bated in normal glucose, with maximum expression seen
at 6 and 12 h (Fig. 2A). The increase of CYP4A protein
expression was accompanied by an increase in 20-HETE
formation, the major biologically active metabolite pro-
duced by CYP4A (Fig. 2B).
20-HETE generated by CYP4A mediates the effect of
high glucose on ROS generation. We next determined
whether CYP4A-derived 20-HETE mediates the effect of
high glucose on ROS generation in podocytes. DCF
ﬂuorescence was used to measure ROS in mouse podo-
cytes exposed to high glucose, in the absence or pres-
ence of N-hydroxy-N-(4-butyl-2-methylphenol) formamidine
(HET0016; 10 mol/l, 1 h), a potent inhibitor of CYP4A
(20-HETE biosynthesis) (34). The increase in ROS gener-
ation induced by high glucose was inhibited by HET0016
(Fig. 2C). Moreover, we show that puriﬁed recombinant
20-HETE (1 mol/l) mimicked the effect of high glucose on
ROS production in podocytes (Fig. 2C). Collectively, these
data indicate that 20-HETE, the major product of the
CYP4A pathway, mediated the effect of high glucose on
ROS in podocytes. Furthermore, the data indicate that the
increase in ROS in podocytes was likely caused by sequen-
tial activation of CYP4A and activation of Nox oxidases.
Redox pathway implicating CYP4A-dependent gener-
ation of 20-HETE mediates the effect of high glucose
on podocyte apoptosis. High glucose has been shown to
induce podocyte apoptosis (7). Data in Fig. 3A and B show
that high glucose induced podocyte apoptosis, as assessed
by annexin V binding and Hoechst staining. This effect was
blocked by the pretreatment of the cells with HET0016,
suggesting that CYP4A contributed to the apoptotic effect
of glucose in podocytes. This concept was further sup-
ported by the ﬁnding that 20-HETE mimicked the effect of
glucose and induced podocyte apoptosis (Fig. 3A and B).
These ﬁndings indicate that the increased CYP4A/20-HETE
production induced ROS generation and resulted in podo-
cyte apoptosis. Annexin V–binding assay detects the trans-
location of phosphatidylserine to the cell surface, an early
event in cells undergoing apoptosis. Hoechst staining, on
the other hand, shows the number of cells with chromatin
condensation, i.e., that have already undergone apoptosis.
20-HETE generation by CYP4A mediates the effect of
high glucose on NADPH oxidase activity and Nox
protein expression and mRNA levels. The observation
that upregulation of CYP4A expression preceded that of
Nox1 and Nox4 oxidases suggests that CYP4A and its
product 20-HETE are responsible for the increased expres-
sion of Nox oxidases and contribute to high-glucose–
induced oxidative stress in podocytes. Nox1 and Nox4
protein and mRNA levels were measured in mouse podo-
cytes exposed to high glucose in the absence or presence
of 10 mol/l HET0016. High glucose increased the expres-
sion of Nox1 and Nox4 proteins as well as mRNA levels of
both oxidases. The increase in Nox1 and Nox4 protein and
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FIG. 1. Temporal effect of high glucose on ROS generation in mouse
podocytes. A: Mouse podocytes were exposed to either high glucose
(HG; 25 mmol/l) or normal glucose (NG; 5 mmol/l) for the indicated
time periods. ROS generation was measured by DCF with a multiwell
ﬂuorescence plate reader as described in RESEARCH DESIGN AND METHODS.
Values are the means  SE of three independent experiments (n  3).
*P < 0.05, high glucose vs. control. B: Mouse podocytes were exposed
to either high glucose (25 mmol/l) or normal glucose (5 mmol/l) for the
indicated time periods. NADPH-dependent superoxide generation was
assessed by lucigenin-enhanced chemiluminescence. Superoxide anion
was expressed as relative chemiluminescent light units (RLU) per
milligram of protein per minute (n  3). C: Expression of Nox1, Nox2,
and Nox4 protein was determined by Western blotting analysis on
homogenized podocytes. Actin was included as a control for loading
and the speciﬁcity of change in protein expression. The Western blot is
representative of three independent experiments (n  3).
A.A. EID AND ASSOCIATES
DIABETES, VOL. 58, MAY 2009 1203mRNA levels in cells exposed to high glucose was inhib-
ited by pretreatment of the cells with HET0016 (Fig.
4A–C). Moreover, treatment of the cells with 1 mol/l
20-HETE mimicked the effect of high glucose and resulted
in an increase in mRNA levels and protein expression of
Nox1 and Nox4 (Fig. 4A–C). These effects were paralleled
by changes in NADPH oxidase activity (Fig. 4D).
CYP4A and 20-HETE mediate diabetes-induced
podocyte apoptosis in OVE26 mice. To determine the in
vivo relevance of the ﬁndings in cultured cells, OVE26
mice were treated with HET0016 for 3 weeks. Mice were
killed, and ﬁndings were compared with nontreated OVE
26 mice and their FVB littermates. The protein expression
of CYP4A was increased in microsomes isolated from
glomeruli of OVE26 mice compared with control FVB mice
(Fig. 5A). NADPH oxidase activity and Nox1/Nox4 protein
expression were upregulated in the OVE26 mice and were
signiﬁcantly decreased in OVE26 mice treated with
HET0016 (Fig. 5B and C). Treatment with HET0016 also
resulted in a decrease in foot process effacement, podo-
cyte apoptosis as observed by EM (Fig. 6A and B), and
synaptopodyn protein expression as assessed by immuno-
histochemistry (Fig. 7A–C). OVE26 diabetic mice treated
with HET0016 exhibited a signiﬁcant decrease in albumin
excretion. Values for urine protein are as follows: 0.035 
0.009 mg per 24 h for the FVB control mice, 4.55  0.6 mg
per 24 h for the OVE26 diabetic mice, and 2.37  0.9 mg
per 24 h for the OVE26 diabetic mice treated with
HET0016 (Fig. 8). Altogether, these data show that ROS
generation through CYP4A and Nox oxidases plays a
critical role in podocyte injury and albuminuria in type 1
diabetes.
DISCUSSION
Podocyte apoptosis is an early glomerular phenotype
that contributes to progressive podocyte depletion and
albuminuria (7). Oxidative stress has been implicated in
the pathogenesis of diabetes complications, including
podocyte apoptosis (13,15,35). We demonstrate that
high glucose induces apoptosis of cultured podocytes
through the generation of ROS via sequential upregula-
tion of CYP4A and the NADPH oxidases Nox1 and Nox4.
We demonstrate, for the ﬁrst time, that 20-HETE, the
major product of CYP4A, enhanced NADPH-dependent
superoxide anion generation, upregulated the expres-
sion of Nox1 and Nox4 proteins, and induced podocyte
apoptosis. Inhibition of CYP4A prevented oxidative
stress and podocyte apoptosis in vitro and reduced
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FIG. 2. CYP4A-dependent 20-HETE production mediates high-glucose–induced ROS generation in mouse podocytes. Serum-deprived podocytes
were preincubated with or without HET0016 (10 mol/l) for 1 h and treated with high glucose (HG; 25 mmol/l) or with 1 mol/l of pure
recombinant 20-HETE for the indicated time periods. A: Expression of CYP4A protein was determined by Western blotting analysis on
microsomes isolated from mouse podocytes. The Western blot is representative of three independent experiments (n  3). B: Microsomes (0.25
mg of protein) prepared from podocytes were incubated with 10 mol/l arachidonic acid in the presence of NADPH. 20-HETE was separated by
reverse-phase HPLC. Values of three independent experiments (n  3) are the means  SE. *P < 0.05, high glucose vs. normal glucose. C: DCF
ﬂuorescence was measured as in Fig. 1. Values are the means  SE of three independent experiments (n  3). *P < 0.05, high glucose or 20-HETE
vs. normal glucose; #P < 0.05, high glucose vs. high glucose  HET0016.
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1204 DIABETES, VOL. 58, MAY 2009FIG. 3. CYP4A-dependent 20-HETE production mediates high-glucose–induced podocyte apoptosis. Serum-deprived podocytes were preincubated
with or without HET0016 (10 mol/l) for 1 h and then treated with high glucose (HG; 25 mmol/l), normal glucose (NG; 5 mmol/l), or 1 mol/l of
recombinant 20-HETE for the indicated time periods. A: Representative photographs of annexin V and propidium iodide staining in different
groups (n  3 in each group). The number of apoptotic or necrotic cells was quantiﬁed by FACS analysis after staining with annexin V and
propidium iodide. The cytograms show viable cells that did not bind annexin V or propidium iodide in the left lower quadrant. Cells at early stages
of apoptosis that bound annexin V but that still had intact cell membranes and excluded propidium iodide are shown in the lower right quadrant.
Cells with advanced stages of apoptosis or necrotic cells were both annexin V positive and propidium iodide positive and are shown in the upper
right quadrant. B: Apoptotic nuclei were detected using Hoechst 33258. Chromatin condensation was examined by ﬂuorescent microscopy. (A
high-quality digital representation of this ﬁgure can be found in the online issue.)
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FIG. 4. CYP4A-dependent 20-HETE production mediates high-glucose–induced Nox1 and Nox4 protein expression and NADPH oxidase activation.
Serum-deprived podocytes were preincubated with or without HET0016 (10 mol/l) for 1 h and treated with high glucose (HG; 25 mmol/l), normal
glucose (NG; 5 mmol/l), or 1 mol/l of pure recombinant 20-HETE for the indicated time periods. Expression of Nox1 (A) and Nox4 (B) protein
was determined by Western blotting analysis on homogenized podocytes. The Western blots are representative of three independent experiments
(n  3). Each histogram represents the ratio of the intensity of the Nox1 or Nox4 bands factored by the actin band. Values are the means  SE.
*P < 0.05, high glucose or 20-HETE vs. normal glucose; #P < 0.05, high glucose vs. high glucose  HET0016. C: Nox1 and Nox4 mRNA levels. The
values represent the relative induction as measured by real-time RT-PCR relative to GAPDH mRNA levels (n  3). The values are the means 
SE. *P < 0.05, high glucose or 20-HETE vs. normal glucose; #P < 0.05, high glucose vs. high glucose  HET0016. D: NADPH-dependent ROS
generation in podocyte homogenates was measured by lucigenin-enhanced chemiluminescence. Superoxide anion is expressed as relative
chemiluminescent light units (RLU) per milligram of protein per minute. Values of three independent experiments (n  3) are the means  SE.
*P < 0.05, high glucose or 20-HETE vs. normal glucose; #P < 0.05, high glucose vs. high glucose  HET0016.
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ment and depletion in OVE26 mice, a well-established
model of type 1 diabetes.
There is good evidence that hyperglycemia and gluco-
toxicity contribute to podocyte injury (7). Diabetes in-
duces oxidative stress, and podocytes are known to be
FIG. 5. CYP4A-dependent 20-HETE production contributes to Nox1 and Nox4 protein expression and NADPH oxidase activity in glomeruli of type
1 diabetic mice. A: Glomeruli were isolated and pooled from ﬁve separate animals. CYP4A protein expression was determined in microsomes from
isolated mouse glomeruli. B: Glomeruli were isolated from the kidney cortex of 6-month-old OVE 26 mice, OVE 26 mice treated for 3 weeks with
HET0016 (2.5 mg  kg
1  day
1 subcutaneously), and their littermate FVB mice. Nox1 and Nox4 protein expression was determined by Western
blotting. Bottom panel: Each histogram represents the ratio of the intensity of Nox1 or Nox4 bands factored by the actin band. Values are the
means  SE. *P < 0.05, OVE26 mice vs. control FVB mice; #P < 0.05, decrease in Nox1 or Nox4 protein expression in HET0016 pretreated OVE26
mice vs. nontreated OVE 26 mice. C: NADPH-dependent ROS generation in glomerular homogenates isolated from the kidney cortex of FVB,
OVE26, and OVE26 mice treated with HET0016 was measured by lucigenin-enhanced chemiluminescence. Superoxide anion is expressed as
relative chemiluminescent light units (RLU) per milligram of protein per minute. Values are the means  SE. *P < 0.05, OVE26 mice vs. control
FVB mice; #P < 0.05, decrease in NADPH oxidase activity in HET0016 pretreated OVE26 mice vs. nontreated OVE 26 mice.
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ous studies demonstrated that intracellular ROS mediate
apoptosis of podocytes in response to ANGII or high
glucose (7,38). Susztak et al. (7) demonstrated that the
apoptotic effect of glucose was inhibited by the superoxide
dismutase mimetic tempol and inhibitors of mitochondrial
respiratory chain and NADPH oxidases. However, the
precise sources of ROS and the kinetics of the increase in
NADPH-dependent superoxide generation have not yet
been examined.
The kidney is known to express NADPH oxidase iso-
forms of the Nox family (13,15,35). At least three different
Nox isoforms are expressed in the kidney cortex: Nox1,
Nox2, and Nox4 (16). In many cells, glucose or ANGII elicit
a rapid (within minutes) increase in ROS generation (7,15).
We also found that high glucose rapidly increased ROS
generation in cultured podocytes. However, there were no
changes in NADPH oxidase activity or expression of Nox
enzymes on short exposure of the cells to high glucose.
This suggests that other sources of ROS may be responsi-
ble for ROS production at early time points after exposure
of the cells to high glucose. There are multiple other
sources of ROS in cells and tissues. ROS generation occurs
as a byproduct of CYP450 enzyme activation. Mitochon-
dria and peroxisomes are also important sources of ROS
(16). CYP4A mRNA and protein are expressed in glomeruli
of mice (20,25). The regulation of CYP4A and 20-HETE
production is tissue- and disease speciﬁc (19). In this
study, we show that CYP4A protein expression and 20-
HETE production were increased within hours of expo-
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FIG. 6. CYP4A contributes to podocyte apoptosis and foot process effacement in glomeruli of type 1 diabetic mice. A: Representative transmission
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(n  5 per group). *P < 0.05, OVE26 mice vs. control FVB mice; #P < 0.05, decrease in the percentage of foot process effacement in OVE26 mice
treated with HET0016 compared with OVE26 mice.
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changes in NADPH oxidase activity or Nox protein expres-
sion were observed. Importantly, we show that ROS
production, Nox oxidases, and apoptosis in response to
glucose were inhibited when the cells were treated with
HET0016, a highly speciﬁc CYP4A inhibitor. Moreover,
addition of exogenous 20-HETE enhanced ROS generation
and induced podocyte apoptosis. Collectively, these data
indicate that CYP4A and 20-HETE generation induced
podocyte apoptosis, and this biological effect was likely
mediated by enhanced ROS production. There is evidence
that 20-HETE mediates cytotoxicity and apoptosis in isch-
emic kidney tubular epithelial cells (27,39). Baliga et al.
(39) also showed that inhibition of CYP450 reduced cell
death in LLC-PK1 cells treated with hydrogen peroxide. It
has been proposed that 20-HETE exerts its deleterious
effect through the generation of ROS. Nilakantam et al.
(27) showed that CYP4A12 overexpression signiﬁcantly
exacerbates the tubular epithelial injury that is associated
with renal ischemia/reperfusion injury and that the pro-
grammed cell death is partially dependent on enhanced
generation of free radicals by CYP4A. On the other hand,
20-HETE appears to play a protective role in pulmonary
artery smooth muscle cells by inhibiting apoptosis (28).
To explore the relevance to type 1 diabetes of our
observations in cultured podocytes, we studied an estab-
lished mouse model of type 1 diabetes, the OVE 26 mouse.
These mice develop morphologic and structural changes
characteristic of human diabetic nephropathy (40,41). We
also demonstrate that OVE26 mice exhibited thickening of
the glomerular basement membrane, foot process efface-
ment, podocyte apoptosis as seen by EM, and podocyte
loss. Urinary albumin excretion in these mice was also
much higher than that seen in the FVB control mice. We
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FIG. 7. CYP4A contributes to podocyte apoptosis and reduction in synaptopodin protein expression in glomeruli of type 1 diabetic mice A:
Representative immunoﬂuorescence images of glomeruli stained with collagen IV (green), synaptopodin (red), and 4,6-diamidino-2-phenylindole
(blue). B: Podocyte number per glomerular section was lower in OVE26 mice, with a signiﬁcant increase in podocyte number in the OVE26 mice
treated with HET0016 (n  5 per group). C: Synaptopodin protein expression in OVE 26 mice was decreased in the OVE26 mice and restored with
the injection of HET0016. Values are the means  SE. *P < 0.05, OVE26 mice vs. control FVB mice; #P < 0.05, decrease in albumin levels in
HET0016-pretreated OVE26 mice vs. nontreated OVE 26 mice (n  5 per group). (A high-quality digital representation of this ﬁgure can be found
in the online issue.)
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microsomes isolated from glomeruli of OVE 26 mice
compared with glomeruli isolated from control FVB mice.
Administration of a speciﬁc inhibitor of 20-HETE produc-
tion, HET0016, to OVE26 mice attenuated albuminuria and
reduced foot process effacement, apoptosis, and podocyte
loss. Inhibition of CYP4A also resulted in downregulation
of Nox1 and Nox4 protein and mRNA expression and
markedly inhibited NADPH oxidase activity. These data
indicate that 20-HETE plays an important role in the
structural and functional changes of podocytes in type 1
diabetes. Whether the decreased expression of Nox1 or
Nox4 contributes to the protective effect of CYP4A inhibi-
tion remains speculative. We recently demonstrated that
NADPH-dependent ROS generation was increased in glo-
meruli of rats with streptozotocin-induced diabetes (13).
Inhibition of Nox4 oxidase using antisense oligonucleotide
therapy reduces glomerular ROS generation, glomerular
hypertrophy, and ﬁbronectin expression 2 weeks after the
induction of type 1 diabetes (13). Urinary protein and
albumin excretion were not measured in these studies.
Sharma et al. (42) recently demonstrated that mouse
podocytes expressed Nox4 and that adiponectin, which
decreased podocyte permeability to albumin in vitro,
reduced Nox4 expression. Therefore, the role of Nox
proteins in mediating the effect of 20-HETE remains to be
explored.
In conclusion, in the current study, we identiﬁed the
sequential upregulation of CYP4A, 20-HETE, and Nox
enzymes as sources of ROS generation that lead to apo-
ptosis of cultured podocytes exposed to high glucose. We
show that this redox pathway plays a key role in podocyte
depletion and proteinuria in type 1 diabetes. These results
suggest that enhanced release of 20-HETE in the diabetic
state contributes to podocyte injury and that inhibitors of
the CYP4A family may be therapeutically useful in the
treatment of diabetic nephropathy.
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